Nursing product for scalp aging resistance and preparation method thereof

By using a combination of multiple active ingredients in scalp care products, the lack of effective scalp anti-aging products on the market has been solved, and multi-dimensional scalp care effects have been achieved, including moisturizing, elastic enhancement, itching reduction and hair promotion.

CN119055548APending Publication Date: 2024-12-03GUANGDONG MARUBI BIOLOGICAL TECH CO LTD +1
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
CN202411227704.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

There is a lack of effective scalp anti-aging care products on the market, which cannot effectively solve scalp aging, hair loss, itching and other problems, affecting the appearance and health of users.

Method used

Provide a scalp anti-aging care product through the synergistic combination of at least six active ingredients, including pyrrolidinyl diaminopyrimidine oxide, water, butyl glycol, soluble collagen, acetyl tetrapeptide-3, kapok extract, Components such as glycerin, betaine, Lactobacillus/soy milk fermentation product filtrate, inulin and α-glucan oligosaccharides form synergistic efficiency and improve the anti-aging ability of nursing products.

Benefits of technology

It achieves multi-dimensional scalp anti-aging effects, including improving scalp moisturizing, skin elasticity, repairing scalp barriers, reducing itching, reducing shedding and promoting hair growth, significantly improving scalp care effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055548A_ABST
    Figure CN119055548A_ABST
Patent Text Reader

Abstract

The invention relates to the field of cosmetics, in particular to a nursing product for scalp aging resistance and a preparation method thereof. The care product comprises an active component and a matrix component, wherein the active component is composed of at least six of a first active matter, a second active matter, a third active matter, a fourth active matter, a fifth active matter, a sixth active matter and a seventh active matter; the care product for scalp aging resistance comprises the following components in percentage by mass: 0-2% of a first active matter, 0-1.5% of a second active matter, 0-10% of a third active matter, 0-0.01% of a fourth active matter, 0-10% of a fifth active matter, 0-10% of a sixth active matter and 0-10% of a seventh active matter, and the balance of matrix components. According to the product, the anti-aging capacity of the scalp care product is improved, and the effects of well preserving moisture, improving skin elasticity, repairing scalp barriers, relieving scalp itching, reducing hair loss and promoting hair growth can be achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of cosmetics, and more specifically, to a scalp anti-aging care product and a preparation method thereof. Background Art

[0002] With the accelerated pace of life and the increase of pressure, scalp problems are becoming more and more common, such as scalp aging, hair loss, itching, dandruff, etc. These problems not only affect the appearance, but may also cause a series of health and psychological problems. Therefore, the market demand for scalp anti-aging care products is growing. People are paying more and more attention to scalp health. More people are beginning to realize the importance of scalp care and are willing to invest more time and money to maintain the health of the scalp.

[0003] However, there are still few scalp anti-aging care products on the market. Summary of the invention

[0004] The purpose of the embodiments of the present application is to provide a scalp anti-aging care product and a preparation method thereof.

[0005] In a first aspect, the present application provides a care product for scalp anti-aging, an active component and a matrix component; wherein the active component is composed of at least six of a first active substance, a second active substance, a third active substance, a fourth active substance, a fifth active substance, a sixth active substance, and a seventh active substance;

[0006] The first active ingredient includes pyrrolidino diaminopyrimidine oxide; the second active ingredient includes diaminopyrimidine oxide; the third active ingredient includes: water, butylene glycol, soluble collagen; the fourth active ingredient includes: acetyl tetrapeptide-3; the fifth active ingredient includes: kapok flower extract, glycerin, betaine, 1,3-propylene glycol, 1,2-pentanediol; the sixth active ingredient includes: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, 1,2-pentanediol; the seventh active ingredient includes: inulin, water, α-glucan oligosaccharide;

[0007] In terms of mass percentage, the following products are used for scalp anti-aging care:

[0008] The first active substance is 0-2%, the second active substance is 0-1.5%, the third active substance is 0-10%, the fourth active substance is 0-0.01%, the fifth active substance is 0-10%, the sixth active substance is 0-10%, the seventh active substance is 0-10%; and the remainder is the matrix component.

[0009] In the above technical solution, the scalp anti-aging care product achieves a synergistic effect by using at least six of the first active substance, the second active substance, the third active substance, the fourth active substance, the fifth active substance, the sixth active substance, and the seventh active substance in a coordinated manner, thereby improving the anti-aging ability of the scalp care product, and can achieve good scalp moisturizing, improve skin elasticity, repair scalp barrier, reduce scalp itching, reduce hair loss, and promote hair growth. And when the first active substance, the second active substance, the third active substance, the fourth active substance, the fifth active substance, the sixth active substance, and the seventh active substance exist at the same time, the synergistic effect is greatly achieved, and scalp anti-aging can be achieved from multiple angles and dimensions, including: scalp stratum corneum water content, scalp transepidermal water loss rate, dandruff reduction, scalp elasticity, scalp erythema, hair loss, hair density effect and other dimensions, greatly improving the scalp care effect.

[0010] In other embodiments of the present application, the active ingredient is Ninoxidil, Unoxidil, COLiance S, SNPep TM At least six of AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, and FLORASKIN L;

[0011] In terms of mass percentage, the following products are used for scalp anti-aging care:

[0012] Ninoxidil 0-2%, Unoxidil 0-1.5%, COLiance S 0-10%, SNPep TM AT-3 0-0.01%, CelCaper supramolecular kapok Pro 0-10%, OPTIMEALTH10W 0-10%, FLORASKIN L 0-10%; the remainder is matrix components.

[0013] In the above technical solution, the scalp anti-aging care product adopts Ninoxidil, Unoxidil, COLiance S, SNPep TM At least six of AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, and FLORASKIN L work together to achieve a synergistic effect, improving the anti-aging ability of scalp care products, and can achieve good scalp moisturizing, improve skin elasticity, repair scalp barrier, reduce scalp itching, reduce hair loss, and promote hair growth. And when Ninoxidil, Unoxidil, COLiance S, SNPep TMWhen AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, and FLORASKIN L are present at the same time, they greatly achieve a synergistic effect, and can achieve multi-dimensional anti-aging of the scalp from multiple angles, including: water content of the scalp stratum corneum, transepidermal water loss rate of the scalp, dandruff reduction, scalp elasticity, scalp erythema, hair loss, hair density effect and other dimensions, greatly improving the scalp care effect.

[0014] In other embodiments of the present application, the above-mentioned scalp anti-aging care products include, by mass percentage:

[0015] Ninoxidil 0.01%-2%, Unoxidil 0.01%-1.5%, COLiance S0.01%-10%, SNPep TM AT-3 0.000001%-0.01%, CelCaper supramolecular kapok Pro 0.01%-10%, OPTIMEALTH10W 0.01%-10%, FLORASKIN L 0.01%-10%; the remainder is matrix components.

[0016] In other embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0017] Ninoxidil 0.1%-1%, Unoxidil 0.5%-1.5%, COLiance S0.5%-6%, SNPep TM AT-3 0.0001%-0.01%, CelCaper supramolecular kapok Pro 0.1%-5%, OPTIMEALTH 10W 0.1%-3%, FLORASKIN L 0.1%-5%; the remainder is matrix components.

[0018] In other embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0019] Ninoxidil 0.5%-1%, Unoxidil 1%-1.5%, COLiance S0.5%-5%, SNPep TM AT-3 0.005%-0.01%, CelCaper supramolecular kapok Pro 2%-5%, OPTIMEALTH 10W 1%-3%, FLORASKIN L 0.5%-5%; the remainder is matrix components.

[0020] In other embodiments of the present application, the matrix component includes:

[0021] Chelating agent, humectant, solubilizer, functional ingredient, thickener, polyol, water.

[0022] In other embodiments of the present application, the chelating agent includes: disodium EDTA;

[0023] In other embodiments of the present application, the moisturizer includes: panthenol;

[0024] In other embodiments of the present application, the effective ingredients include: creatine, niacinamide;

[0025] In other embodiments of the present application, the thickener includes: polyacrylate crosspolymer-6.

[0026] In other embodiments of the present application, the solubilizer includes: PEG-40 hydrogenated castor oil.

[0027] In other embodiments of the present application, the polyol includes at least one of glycerol, propylene glycol, 1,3-propanediol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, sorbitol, dipropylene glycol, erythritol, and methylpropanediol.

[0028] In other embodiments of the present application, the matrix component includes:

[0029] Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Water.

[0030] In other embodiments of the present application, the matrix component includes, by mass percentage:

[0031] 0.01%-0.1% disodium EDTA, 0.1%-1% panthenol, 0.1%-1% creatine, 1%-5% niacinamide, 0.1%-0.5% polyacrylate crosspolymer-6, 1%-10% 1,2-pentanediol, 0.05%-0.2% PEG-40 hydrogenated castor oil; the balance is water.

[0032] In other embodiments of the present application, COLiance S includes: water, butylene glycol, soluble collagen;

[0033] In other embodiments of the present application, CelCaper supramolecular kapok Pro comprises: kapok (BOMBAXMALABARICUM) flower extract, glycerin, betaine, 1,3-propylene glycol, 1,2-pentanediol;

[0034] In other embodiments of the present application, OPTIMEALTH 10W includes: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, 1,2-pentanediol;

[0035] In other embodiments of the present application, FLORASKIN L comprises: inulin, water, and α-glucan oligosaccharide.

[0036] In a second aspect, the present application provides a method for preparing a scalp anti-aging care product.

[0037] Anti-aging products for the scalp include:

[0038] Water, Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, 1,2-Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Ninoxidil, Unoxidil, COLianceS, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L;

[0039] The preparation method comprises:

[0040] Mix water, disodium EDTA, panthenol, creatine, niacinamide, polyacrylate cross-polymer-6, 1,2-pentanediol, Ninoxidil, and Unoxidil, heat to 80° C. to 90° C., and keep the temperature to obtain a first mixture;

[0041] Heat PEG-40 hydrogenated castor oil to 40° C. to 50° C. to obtain a second material;

[0042] The first mixed material is cooled to 40°C to 50°C; then the second material is added to the first mixed material; and COLiance S, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0044] Figure 1 The results of the scalp stratum corneum moisture content test are shown;

[0045] Figure 2 The results of the scalp transepidermal water loss test are shown;

[0046] Figure 3 Dandruff test results are shown;

[0047] Figure 4 The results of the scalp elasticity test are shown;

[0048] Figure 5 Scalp erythema test results are shown;

[0049] Figure 6 The results of the hair loss test are shown;

[0050] Figure 7 The results of the hair density test are shown. DETAILED DESCRIPTION

[0051] In order to make the purpose, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments.

[0052] Therefore, the following detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.

[0053] With the development of science and technology, the research and development technology of scalp anti-aging care products is also constantly improving. For example, new scalp massagers, light therapy helmets, scalp care essences and other products have been launched one after another. These products improve scalp problems and improve the health of the scalp through various methods such as physics and chemistry.

[0054] As people's demand for beauty and skin care continues to grow, the market demand for scalp anti-aging products is also increasing. Consumers' demand for scalp anti-aging products is also constantly upgrading. They not only pay attention to the efficacy and safety of the products, but also pay attention to the product experience and service quality. Therefore, it is necessary to continuously improve the quality of products and service levels to meet consumer needs.

[0055] As an important sub-segment of beauty and skin care, the scalp anti-aging industry has broad development prospects. At the same time, the scalp anti-aging industry also faces some challenges, such as fierce market competition and insufficient consumer awareness. Therefore, it is necessary to increase R&D efforts, continue to innovate, and provide better products and services to stand out in the market competition.

[0056] In summary, the research and development background of scalp anti-aging care is mainly due to the consideration of market demand growth, scientific and technological progress, industry development trends and consumer demand upgrades. These factors jointly promote the research and development and development of scalp anti-aging care products.

[0057] Therefore, it is very necessary to provide a gentle and effective scalp anti-aging care product.

[0058] The embodiment of the present application provides a care product for scalp anti-aging, an active component and a matrix component; wherein the active component is composed of at least six of a first active substance, a second active substance, a third active substance, a fourth active substance, a fifth active substance, a sixth active substance, and a seventh active substance;

[0059] The first active ingredient includes pyrrolidino diaminopyrimidine oxide; the second active ingredient includes diaminopyrimidine oxide; the third active ingredient includes: water, butylene glycol, soluble collagen; the fourth active ingredient includes: acetyl tetrapeptide-3; the fifth active ingredient includes: kapok flower extract, glycerin, betaine, 1,3-propylene glycol, 1,2-pentanediol; the sixth active ingredient includes: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, 1,2-pentanediol; the seventh active ingredient includes: inulin, water, α-glucan oligosaccharide;

[0060] In terms of mass percentage, the following products are used for scalp anti-aging care:

[0061] The first active substance is 0-2%, the second active substance is 0-1.5%, the third active substance is 0-10%, the fourth active substance is 0-0.01%, the fifth active substance is 0-10%, the sixth active substance is 0-10%, the seventh active substance is 0-10%; and the remainder is the matrix component.

[0062] In the above technical solution, the scalp anti-aging care product achieves a synergistic effect by using at least six of the first active substance, the second active substance, the third active substance, the fourth active substance, the fifth active substance, the sixth active substance, and the seventh active substance in a coordinated manner, thereby improving the anti-aging ability of the scalp care product, and can achieve good scalp moisturizing, improve skin elasticity, repair scalp barrier, reduce scalp itching, reduce hair loss, and promote hair growth. And when the first active substance, the second active substance, the third active substance, the fourth active substance, the fifth active substance, the sixth active substance, and the seventh active substance exist at the same time, the synergistic effect is greatly achieved, and scalp anti-aging can be achieved from multiple angles and dimensions, including: scalp stratum corneum water content, scalp transepidermal water loss rate, dandruff reduction, scalp elasticity, scalp erythema, hair loss, hair density effect and other dimensions, greatly improving the scalp care effect.

[0063] In some embodiments of the present application, the active ingredient is Ninoxidil, Unoxidil, COLiance S, SNPep TM At least six of AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, and FLORASKIN L;

[0064] In terms of mass percentage, the following products are used for scalp anti-aging care:

[0065] Ninoxidil 0-2%, Unoxidil 0-1.5%, COLiance S 0-10%, SNPep TM AT-3 0-0.01%, CelCaper supramolecular kapok Pro 0-10%, OPTIMEALTH10W 0-10%, FLORASKIN L 0-10%; the remainder is matrix components.

[0066] In the above technical solution, the scalp anti-aging care product adopts Ninoxidil, Unoxidil, COLiance S, SNPep TM The synergistic combination of at least six ingredients, including AT-3, CelCaper supramolecular kapok Pro, OPTIMEALTH 10W, and FLORASKIN L, has improved the anti-aging ability of scalp care products, achieving better moisturizing, improving skin elasticity, repairing the scalp barrier, alleviating scalp itching, reducing hair loss, and promoting hair growth.

[0067] Further optionally, in some embodiments of the present application, the active ingredient is Ninoxidil, Unoxidil, COLiance S, SNPep TM AT-3, CelCaper supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L; can be composed of any six of the above 7 raw materials; or composed of seven raw materials. For example, in some embodiments of the present application, the active ingredient is Ninoxidil, Unoxidil, COLiance S, SNPep TM AT-3, CelCaper supramolecular kapok Pro, OPTIMEALTH 10W, FLORASKIN L, or in some embodiments of the present application, the above active ingredients are Ninoxidil, Unoxidil, COLianceS, SNPep TM AT-3, CelCaper supramolecular Kapok Pro, OPTIMEALTH 10W; or in some embodiments of the present application, the above active ingredients are Ninoxidil, Unoxidil, COLiance S, SNPep TMAT-3, CelCaper supramolecular Kapok Pro, FLORASKIN L; or in some embodiments of the present application, the above active ingredients are Unoxidil, COLiance S, SNPep TM It consists of six types: AT-3, CelCaper supramolecular kapok Pro, OPTIMEALTH 10W, and FLORASKIN L.

[0068] Further, in some embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0069] Ninoxidil 0-2%, Unoxidil 0-1.5%, COLiance S 0-10%, SNPep TM AT-3 0-0.01%, CelCaper supramolecular kapok Pro 0-10%, OPTIMEALTH10W 0-10%, FLORASKIN L 0-10%; the remainder is matrix components.

[0070] Further optionally, in some embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0071] Ninoxidil 0.01%-2%, Unoxidil 0.01%-1.5%, COLiance S0.01%-10%, SNPep TM AT-3 0.000001%-0.01%, CelCaper supramolecular kapok Pro 0.01%-10%, OPTIMEALTH10W 0.01%-10%, FLORASKIN L 0.01%-10%; the remainder is matrix components.

[0072] For example, in some embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0073] Ninoxidil 0.01%, 0.02%, 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.8%, 1%, 1.2%, 1.5%, 1.8%, 1.9%, 2% or the range between any two of the foregoing values;

[0074] Unoxidil 0.01%, 0.02%, 0.05%, 0.08%, 0.1%, 0.2%, 0.5%, 0.8%, 0.11%, 0.12%, 0.13%, 0.14%, 1.5% or the range between any two of the foregoing values;

[0075] COLiance S 0.01%, 0.02%, 0.05%, 0.08%, 0.1%, 0.2%, 0.5%, 0.8%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or the range between any two of the foregoing values;

[0076] SNPep TM AT-3 0.000001%, 0.000005%, 0.00001%, 0.0001%, 0.001%, 0.002%, 0.003%, 0.004%, 0.005%, 0.006%, 0.007%, 0.008%, 0.009%, 0.01% or the range between any two of the foregoing values;

[0077] CelCaper Supramolecular Kapok Pro 0.01%, 0.02%, 0.05%, 0.1%, 0.2%, 0.5%, 0.8%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or the range between any two of the above values;

[0078] OPTIMEALTH 10W 0.01%, 0.02%, 0.05%, 0.08%, 0.1%, 0.5%, 0.8%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or the range between any two of the foregoing values;

[0079] FLORASKIN L 0.01%, 0.05%, 0.08%, 0.1%, 0.2%, 0.3%, 0.5%, 0.8%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or the range between any two of the foregoing values; the balance is matrix components.

[0080] Further optionally, in some embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0081] Ninoxidil 0.1%-1%, Unoxidil 0.5%-1.5%, COLiance S0.5%-6%, SNPep TM AT-3 0.0001%-0.01%, CelCaper supramolecular kapok Pro 0.1%-5%, OPTIMEALTH 10W 0.1%-3%, FLORASKIN L 0.1%-5%; the remainder is matrix components.

[0082] Further optionally, in some embodiments of the present application, the scalp anti-aging care product includes, by mass percentage:

[0083] Ninoxidil 0.5%-1%, Unoxidil 1%-1.5%, COLiance S0.5%-5%, SNPep TM AT-3 0.005%-0.01%, CelCaper supramolecular kapok Pro 2%-5%, OPTIMEALTH 10W 1%-3%, FLORASKIN L 0.5%-5%; the remainder is matrix components.

[0084] Furthermore, in some embodiments of the present application, COLiance S includes: water, butylene glycol, and soluble collagen.

[0085] Furthermore, in some embodiments of the present application, CelCaper supramolecular kapok Pro comprises: kapok (BOMBAX MALABARICUM) flower extract, glycerin, betaine, 1,3-propylene glycol, and 1,2-pentanediol.

[0086] Further, in some embodiments of the present application, OPTIMEALTH 10W includes: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, and 1,2-pentanediol.

[0087] Furthermore, in some embodiments of the present application, FLORASKIN L comprises: inulin, water, and α-glucan oligosaccharide.

[0088] For example, in some embodiments of the present application, Ninoxidil [INCI: pyrrolidino diaminopyrimidine oxide, produced by Tianjin Taipu Pharmaceutical Co., Ltd.], Unoxidil [INCI: diaminopyrimidine oxide, produced by Tianjin Taipu Pharmaceutical Co., Ltd.], COLiance S [INCI: water, butylene glycol, soluble collagen, produced by HYUNDAIBIOLANDCO.LTD], CelCaper supramolecular kapok Pro [INCI: kapok (BOMBAX MALABARICUM) flower extract, glycerin, betaine, 1,3-propylene glycol, 1,2-pentanediol, produced by Best Pharmaceuticals], OPTIMEALTH 10W [INCI: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, 1,2-pentanediol, produced by Xianting], FLORASKIN L [INCI: inulin, water, α-glucan oligosaccharide, produced by Xianting], SNPep TM AT-3 [INCI: Acetyl Tetrapeptide-3, manufactured by Chengdu Kaijie].

[0089] Furthermore, in some embodiments of the present application, Ninoxidil opens potassium ion channels through the vasodilation mechanism around the hair follicles, improves scalp microcirculation, promotes the absorption of nutrients required for hair growth, and promotes the proliferation of hair papilla cells; inhibits the activity of 5α-reductase, thereby reducing the conversion of testosterone to DHT and avoiding the miniaturization of hair follicles.

[0090] Unoxidil interferes with the production of mature collagen by fibroblasts by inhibiting the expression of lysine hydroxylase (LH) mRNA, and prevents the deposition of mature collagen, thereby avoiding hardening, shrinkage and hair loss of hair follicles; it inhibits the activity of 5α-reductase, thereby reducing the conversion of testosterone to DHT and avoiding the miniaturization of hair follicles.

[0091] COLiance S helps in hair growth by providing nutrition to hair follicles and strengthening hair follicles.

[0092] CelCaper Supramolecular Kapok Pro has a strong antioxidant effect and can resist skin inflammatory aging.

[0093] OPTIMEALTH 10W repairs the scalp barrier and reduces the effects of allergies.

[0094] FLORASKIN L can regulate the scalp microecology, promote the growth of scalp probiotics, inhibit the reproduction of harmful bacteria on the scalp, and enhance the scalp's immunity.

[0095] SNPep TM AT-3 is a biomimetic peptide composed of four amino acids, which can mimic the signal peptides in the human body that stimulate tissue remodeling, promote cell proliferation, differentiation and intercellular communication, accelerate the synthesis of collagen and laminin, and stimulate the development of hair follicles. It can effectively improve the structure of hair follicles, strengthen and stabilize hair, prevent and reduce hair loss, and stimulate natural hair growth, making hair thicker and firmer.

[0096] The above-mentioned active ingredients work synergistically with each other to improve the anti-aging ability of scalp care products, and can achieve better moisturizing, improve skin elasticity, repair the scalp barrier, reduce scalp itching, reduce hair loss and promote hair growth.

[0097] Further, in some embodiments of the present application, the matrix component includes:

[0098] Chelating agent, humectant, solubilizer, functional ingredient, thickener, polyol, water.

[0099] Further optionally, in some embodiments of the present application, the chelating agent includes: disodium EDTA.

[0100] Further optionally, in some embodiments of the present application, the moisturizing agent includes: panthenol.

[0101] Further optionally, in some embodiments of the present application, the effective ingredients include: creatine and niacinamide.

[0102] Further optionally, in some embodiments of the present application, the thickener includes: polyacrylate cross-linked polymer-6.

[0103] Further optionally, in some embodiments of the present application, the solubilizer includes: PEG-40 hydrogenated castor oil.

[0104] Further optionally, in some embodiments of the present application, the polyol includes at least one of glycerol, propylene glycol, 1,3-propanediol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, sorbitol, dipropylene glycol, erythritol, and methylpropanediol.

[0105] Further optionally, in some embodiments of the present application, the matrix component includes:

[0106] Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Water.

[0107] Further optionally, in some embodiments of the present application, the matrix component comprises, by mass percentage:

[0108] 0.01%-0.1% disodium EDTA, 0.1%-1% panthenol, 0.1%-1% creatine, 1%-5% niacinamide, 0.1%-0.5% polyacrylate crosspolymer-6, 1%-10% 1,2-pentanediol, 0.05%-0.2% PEG-40 hydrogenated castor oil; the balance is water.

[0109] For example, in some embodiments of the present application, the matrix component includes, by weight percentage:

[0110] 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% or a range between any two of the foregoing values ​​of disodium EDTA;

[0111] 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or a range between any two of the foregoing values ​​of panthenol;

[0112] 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or a range between any two of the foregoing values ​​of creatine;

[0113] 1%, 1.5%, 2%, 2.5%, 3%, 4%, 4.5%, 4.8%, 5% or a range between any two of the foregoing niacinamide;

[0114] 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.4%, 0.45%, 0.5% or the range between any two of the foregoing values ​​of polyacrylate cross-linked polymer-6;

[0115] 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or the range between any two of the above values ​​1,2-Pentanediol

[0116] 0.05%, 0.08%, 0.1%, 0.15%, 0.16%, 0.17%, 0.18%, 0.19%, 0.2% or the range between any two of the foregoing values ​​PEG-40 hydrogenated castor oil; the balance water.

[0117] Some embodiments of the present application provide a method for preparing a scalp anti-aging care product. The scalp anti-aging care product comprises:

[0118] Water, Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, 1,2-Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Ninoxidil, Unoxidil, COLianceS, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L;

[0119] The preparation method comprises:

[0120] Mix water, disodium EDTA, panthenol, creatine, niacinamide, polyacrylate cross-polymer-6, 1,2-pentanediol, Ninoxidil, and Unoxidil, heat to 80° C. to 90° C., and keep the temperature to obtain a first mixture;

[0121] Heat PEG-40 hydrogenated castor oil to 40° C. to 50° C. to obtain a second material;

[0122] The first mixed material is cooled to 40°C to 50°C; then the second material is added to the first mixed material; and COLiance S, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L.

[0123] Illustratively, in some embodiments of the present application, the preparation method comprises:

[0124] Mix water, disodium EDTA, panthenol, creatine, niacinamide, polyacrylate crosspolymer-6, 1,2-pentanediol, Ninoxidil, and Unoxidil, heat to 80° C., 81° C., 82° C., 83° C., 84° C., 85° C., 86° C., 87° C., 88° C., 89° C., 90° C., or a range between any two of the foregoing values, and keep warm to obtain a first mixture;

[0125] Heat PEG-40 hydrogenated castor oil to 40° C., 41° C., 42° C., 43° C., 44° C., 45° C., 46° C., 47° C., 48° C., 49° C., 50° C., or a range between any two of the foregoing values ​​to obtain a second material;

[0126] Cool the first mixed material to 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C or a range between any two of the foregoing values; then add the second material to the first mixed material; and COLiance S, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L.

[0127] In other optional embodiments of the present application, ingredients such as fragrances and preservatives may also be added to the above-mentioned scalp anti-aging care products.

[0128] For example, in some embodiments of the present application, 0.01%-0.05% of flavor may be added by mass percentage.

[0129] The features and performance of the present application are further described in detail below in conjunction with the embodiments:

[0130] Examples and Comparative Examples

[0131] Provided is a scalp anti-aging care product. The compositions of the embodiments and comparative examples are shown in Table 1 in terms of mass percentage.

[0132] Table 1

[0133]

[0134]

[0135] The preparation processes of various embodiments and comparative examples are as follows:

[0136] Step S1: clean and disinfect the production equipment and related production tools thoroughly, and dry them.

[0137] Step S2, mix and stir the raw materials of sequence numbers (1), (2), (3), (4), (5), (6), (7), (10), and (11), heat to 85° C., and keep the temperature for 30 minutes to obtain a material body.

[0138] Step S3, stirring and heating the raw materials of sequence numbers (8) and (9) to 45° C. and stirring evenly.

[0139] Step S4: After the material obtained in step S2 is cooled to 45° C., add the material obtained in step S3 and the raw materials of sequence numbers (12), (13), (14), (15), and (16), and stir evenly.

[0140] Step S5, filtering the material with a 500-mesh filter cloth.

[0141] Experimental example

[0142] The performance of the samples prepared in various embodiments and comparative examples was tested.

[0143] 1. Mildness evaluation:

[0144] 1. Human skin patch test: Using the closed patch test method, 8 groups of comparative examples and 8 groups of example materials were placed in patch testers, respectively, and applied to the backs of 30 subjects. The test materials were removed after 24 hours, and the skin reactions were observed at 0.5 hours, 24 hours, and 48 hours after removal.

[0145] Observation results: No adverse skin reaction occurred in 30 subjects.

[0146] 2. Chicken embryo chorioallantoic membrane experiment: The experiment was conducted using the endpoint evaluation method. Six chicken embryos were used in each group for parallel experiments. Eight groups of comparative examples and eight groups of examples were evaluated.

[0147] Experimental results: There was no bleeding, no coagulation, and no vascular lysis in each embodiment and comparative example.

[0148] This shows that the results of the human skin patch test and the chicken embryo chorioallantoic membrane test both indicate that the scalp care samples provided in the above-mentioned embodiments and comparative examples are mild.

[0149] 2. Efficacy Test Verification

[0150] The test substances (Comparative Examples 1-8 and Examples 1-8, a total of 16 groups) were used in a product trial on 160 subjects for 28 days. The left symmetrical area was not used with the product, while the right symmetrical area was used with the test substances for comparison, with 10 subjects in each group.

[0151] (1) After the test subjects used the test substances, the water content of the scalp stratum corneum was analyzed by instrumental testing. After continuous use for 28 days, the water content of the scalp stratum corneum, transepidermal water loss rate of the scalp, erythema, dandruff, scalp elasticity, amount of hair loss and scalp density were tested and analyzed by instrumental testing to evaluate the moisturizing, scalp barrier repair, elasticity, anti-hair loss and hair growth effects of the test substances of Comparative Examples 1-8 and Examples 1-8.

[0152] The test results are shown in the attached manual. Figure 1 ~Attached Figure 7 . Instructions attached Figure 1 The test results of the scalp stratum corneum water content are shown; Figure 1 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to increase the water content of the scalp stratum corneum, and the effect is significantly better than that of comparative examples 1-8.

[0153] Instructions attached Figure 2 The results of the scalp transepidermal water loss test are shown in the instruction manual. Figure 2 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to reduce the transepidermal water loss rate of the scalp, and the effect is significantly better than that of comparative examples 1-8.

[0154] Instructions attached Figure 3 Shows the dandruff test results; attached to the instruction manual Figure 3 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to reduce dandruff production, and the effect is significantly better than that of comparative examples 1-8.

[0155] Instructions attached Figure 4 The scalp elasticity test results are shown; Figure 4 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to improve scalp elasticity, and the effect is significantly better than that of comparative examples 1-8.

[0156] Instructions attached Figure 5 The scalp erythema test results are shown; Figure 5 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to reduce scalp erythema, and the effect is significantly better than that of comparative examples 1-8.

[0157] Instructions attached Figure 6 Shows the test results of hair loss; attached to the instruction manual Figure 6 It can be seen from the above data analysis that the scalp anti-aging care product of the present application helps to reduce hair loss, and the effect is significantly better than that of comparative examples 1-8.

[0158] Instructions attached Figure 7Shows the test results of hair density; Figure 7 It can be seen from the above data analysis that the scalp anti-aging care product of the present application is helpful for hair growth, and the effect is significantly better than that of comparative examples 1-8.

[0159] By the above attachment Figure 1 -Attached Figure 7 The test results show that the present application scheme improves the anti-aging ability of scalp care products through the synergistic combination of at least six active ingredients mentioned above, and can achieve better moisturizing, improve skin elasticity, repair scalp barrier, reduce scalp itching, reduce hair loss and promote hair growth. TM When AT-3, CelCaper supramolecular kapok Pro, OPTIMEALTH 10W, and FLORASKIN L are present at the same time, synergistic enhancement is greatly achieved, and the scalp anti-aging (the scalp anti-aging of this application is from multiple angles, achieving multi-dimensional anti-aging, including: scalp stratum corneum water content, scalp transepidermal water loss rate, dandruff reduction, scalp elasticity, scalp erythema, hair loss, hair density) effect is optimal.

[0160] (2) After the subjects used the test substance for 28 consecutive days, they were asked to self-evaluate their scalp itching sensation by completing a questionnaire.

[0161] Self-assessment of subjects: A questionnaire survey was conducted to ask subjects to self-evaluate the degree of improvement in the severity of scalp itching.

[0162] The test results are shown in the following table:

[0163] Table 2

[0164] Test Group Evaluation results of scalp itching sensation (consumer questionnaire results, 00 people in each group) Comparative Example 1 One subject had a significant improvement in scalp itching, while the other subjects had no significant improvement Comparative Example 2 The scalp itching sensation of 3 subjects was significantly improved, while the effect was not obvious for the other subjects Comparative Example 3 Two subjects had a significant improvement in scalp itching, while the rest had no significant effect. Comparative Example 4 The scalp itching sensation was significantly improved in 5 subjects, but the effect was not obvious in the other subjects. Comparative Example 5 The scalp itching sensation of 4 subjects was significantly improved, while the effect was not obvious for the other subjects Comparative Example 6 The scalp itching sensation of 3 subjects was significantly improved, while the effect was not obvious for the other subjects Comparative Example 7 8 subjects had significant improvement in scalp itching, while the rest had no significant improvement Comparative Example 8 Seven subjects had a significant improvement in scalp itching, while the rest had no significant effect. Example 1 All 10 subjects had significant improvement in scalp itching Example 2 All 10 subjects had significant improvement in scalp itching Example 3 All 10 subjects had significant improvement in scalp itching Example 4 All 10 subjects had significant improvement in scalp itching Example 5 All 10 subjects had significant improvement in scalp itching Example 6 All 10 subjects had significant improvement in scalp itching Example 7 All 10 subjects had significant improvement in scalp itching Example 8 All 10 subjects had significant improvement in scalp itching

[0165] From the above data analysis, the scalp care product of the present invention can significantly improve scalp itching, and the effects of Examples 1-8 are significantly better than those of Comparative Examples 1-8.

[0166] Based on the above data analysis, the scalp anti-aging care product of the present application can significantly increase the water content of the scalp stratum corneum, scalp elasticity, and hair density; significantly reduce the scalp transepidermal water loss rate, dandruff, scalp erythema, scalp shedding, and scalp itching, and has the effects of improving scalp dryness, soothing the scalp, repairing the scalp barrier, improving scalp elasticity, reducing hair loss and promoting hair growth, and resisting scalp aging.

[0167] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A scalp anti-aging care product, characterized in that: An active component and a matrix component; wherein the active component is composed of at least six of a first active substance, a second active substance, a third active substance, a fourth active substance, a fifth active substance, a sixth active substance, and a seventh active substance; The first active substance includes pyrrolidino diaminopyrimidine oxide; the second active substance includes diaminopyrimidine oxide; the third active substance includes: water, butylene glycol, soluble collagen; the fourth active substance includes: acetyl tetrapeptide-3; the fifth active substance includes: kapok flower extract, glycerin, betaine, 1,3-propylene glycol, 1,2-pentanediol; the sixth active substance includes: water, lactobacillus / soy milk fermentation product filtrate, butylene glycol, 1,2-pentanediol; the seventh active substance includes: inulin, water, α-glucan oligosaccharide; In terms of mass percentage, the scalp anti-aging care product comprises: The first active ingredient is 0-2%, the second active ingredient is 0-1.5%, the third active ingredient is 0-10%, the fourth active ingredient is 0-0.01%, the fifth active ingredient is 0-10%, the sixth active ingredient is 0-10%, the seventh active ingredient is 0-10%; and the remainder is matrix components.

2. The scalp anti-aging care product according to claim 1, characterized in that: The active ingredients are Ninoxidil, Unoxidil, COLiance S, SNPep TM At least six of AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, and FLORASKIN L; In terms of mass percentage, the scalp anti-aging care product comprises: Ninoxidil 0-2%, Unoxidil 0-1.5%, COLiance S 0-10%, SNPep TM AT-3 0-0.01%, CelCaper supramolecular kapok Pro 0-10%, OPTIMEALTH 10W 0-10%, FLORASKIN L 0-10%; the remainder is matrix components.

3. The scalp anti-aging care product according to claim 1, characterized in that: In terms of mass percentage, the scalp anti-aging care product comprises: Ninoxidil 0.01%-2%, Unoxidil 0.01%-1.5%, COLiance S 0.01%-10%, SNPep TM AT-3 0.000001%-0.01%, CelCaper supramolecular kapok Pro 0.01%-10%, OPTIMEALTH10W 0.01%-10%, FLORASKIN L 0.01%-10%; the remainder is matrix components.

4. The scalp anti-aging care product according to claim 1, characterized in that: In terms of mass percentage, the scalp anti-aging care product comprises: Ninoxidil 0.1%-1%, Unoxidil 0.5%-1.5%, COLiance S 0.5%-6%, SNPep TM AT-3 0.0001%-0.01%, CelCaper supramolecular kapok Pro 0.1%-5%, OPTIMEALTH 10W 0.1%-3%, FLORASKIN L 0.1%-5%; the remainder is matrix components.

5. The scalp anti-aging care product according to claim 1, characterized in that: In terms of mass percentage, the scalp anti-aging care product comprises: Ninoxidil 0.5%-1%, Unoxidil 1%-1.5%, COLiance S 0.5%-5%, SNPep TM AT-3 0.005%-0.01%, CelCaper supramolecular kapok Pro 2%-5%, OPTIMEALTH 10W 1%-3%, FLORASKIN L 0.5%-5%; the remainder is matrix components.

6. The scalp anti-aging care product according to any one of claims 1 to 4, characterized in that: The matrix components include: Chelating agent, humectant, solubilizer, functional ingredient, thickener, polyol, water.

7. The scalp anti-aging care product according to claim 5, characterized in that: The chelating agent includes: disodium EDTA; Optionally, the moisturizer includes: panthenol; Optionally, the effective ingredients include: creatine, niacinamide; Optionally, the thickener includes: polyacrylate cross-linked polymer-6; Optionally, the solubilizing agent comprises: PEG-40 hydrogenated castor oil; Optionally, the polyol includes at least one of glycerol, propylene glycol, 1,3-propanediol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, sorbitol, dipropylene glycol, erythritol, and methyl propanediol.

8. The scalp anti-aging care product according to claim 5, characterized in that: The matrix components include: Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Water.

9. The scalp anti-aging care product according to claim 5, characterized in that: In terms of mass percentage, the matrix components include: 0.01%-0.1% disodium EDTA, 0.1%-1% panthenol, 0.1%-1% creatine, 1%-5% niacinamide, 0.1%-0.5% polyacrylate crosspolymer-6, 1%-10% 1,2-pentanediol, 0.05%-0.2% PEG-40 hydrogenated castor oil; the balance is water.

10. The method for preparing the scalp anti-aging care product according to any one of claims 1 to 9, characterized in that: The scalp anti-aging care product comprises: Water, Disodium EDTA, Panthenol, Creatine, Niacinamide, Polyacrylate Crosspolymer-6, Pentylene Glycol, PEG-40 Hydrogenated Castor Oil, Ninoxidil, Unoxidil, COLiance S, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L; The preparation method comprises: Mix water, disodium EDTA, panthenol, creatine, niacinamide, polyacrylate cross-polymer-6, 1,2-pentanediol, Ninoxidil, and Unoxidil, heat to 80° C. to 90° C., and keep the temperature to obtain a first mixture; Heat PEG-40 hydrogenated castor oil to 40° C. to 50° C. to obtain a second material; The first mixed material is cooled to 40°C to 50°C; the second material is then added to the first mixed material; and COLiance S, SNPep TM AT-3, CelCaper Supramolecular Kapok Pro, OPTIMEALTH 10W, FLORASKIN L.

Citation Information

Patent Citations

  • Tea cake hair-care composition and preparation method thereof

    CN106692021A

  • Scalp care composition and application thereof

    CN111973545A

  • Nano composition with hair loss preventing, hair growing, hair fixing and hair blackening functions as well as preparation method and application thereof

    CN112516006A

  • Anti-hair loss and hair growth composition and preparation method thereof

    CN113648271A

  • Hair loss preventing and hair nourishing composition and preparation method thereof

    CN114344188A